CGON logo

CG Oncology, Inc. (CGON)

Profile

Full Name

CG Oncology, Inc.

Ticker

NASDAQ: CGON

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

Indexes

Not included

Website

http://cgoncology.com

Employees

113

Key Details

Price

$26.72(-1.44%)

Market cap

$2.04B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.14M(+458.33% YoY)

Annual EPS

-$1.41(-32.02% YoY)

PE ratio

-

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $26.72
    CGON price is $26.72

    30-Day Relative Volume

    0.44
    CGON 30-day relative volume is 0.44

    Price Performance

    Price Most recent change

    -1.44%
    CGON price was down -1.44% on Jul 11, 2025

    Price YTD change

    -6.83%
    CGON price is down -6.83% since January 1st

    Price 1-year change

    -22.46%
    CGON price is down -22.46% year-on-year

    Price 3-year change

    -
    CGON price 3-year change is unknown

    Price Range

    Price All-time high

    $50.23
    CGON price is currently -46.80% below its historical high of $50.23

    Price 3-year low

    $14.80
    CGON price is currently +80.54% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.04B
    CGON market capitalization is $2.04 billion

    Market cap 3-year change

    -
    CGON market capitalization 3-year change is unknown

    Market cap All-time high

    $3.19B
    CGON market capitalization is currently -36.08% below its historical high of $3.19 billion

    Market cap sector rank

    82.48%
    CGON market capitalization is higher than 82.48% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +14.35%
    CGON shares outstanding is up +14.35% year-on-year

    Shares Outstanding 3-Year Change

    -
    CGON shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.56
    CGON beta is 1.56

    200-day SMA

    $29.04
    CGON price is currently -7.99% below its 200-day simple moving average

    50-day SMA

    $25.96
    CGON price is currently +2.91% above its 50-day simple moving average

    RSI

    54.53
    CGON 14-day relative strength index is 54.53

    Volume

    0.44
    CGON 30-day relative volume is 0.44

    ATR

    $1.02
    CGON average true range is $1.02

    10-day Historical Volatility

    29.05%
    CGON 10-day historical volatility is 29.05%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.14M
    CGON annual revenue is $1.14 million

    Revenue Analysts estimate

    $450.88K
    CGON annual revenue is currently +152.62% higher than the consensus analysts' forecast

    Revenue 1-year change

    +458.33%
    CGON annual revenue is up +458.33% year-on-year

    Revenue Sector rank

    13.17%
    CGON annual revenue is higher than 13.17% of companies in Healthcare sector

    EPS

    EPS

    -$1.41
    CGON annual earnings per share is -$1.41

    EPS Analysts estimate

    -$1.81
    CGON annual earnings per share is currently -21.96% lower than the consensus analysts' forecast

    EPS 1-year change

    -32.02%
    CGON annual earnings per share is down -32.02% year-on-year

    EPS Sector rank

    47.59%
    CGON annual earnings per share is higher than 47.59% of companies in Healthcare sector

    Profit

    Gross profit

    -
    CGON annual gross profit value is unknown

    Gross margin

    -
    CGON annual gross profit margin value is unknown

    Operating profit

    -$114.67M
    CGON annual operating income is -$114.67 million

    Operating margin

    -10.07K%
    CGON annual operating profit margin is -10.07 thousand%

    Net income

    -$88.04M
    CGON annual net profit is -$88.04 million

    Net margin

    -7729.50%
    CGON annual net profit margin is -7729.50%

    Expenses

    Total expenses

    $115.81M
    CGON annual total expenses is $115.81 million

    Operating expenses

    $115.81M
    CGON annual total operating expenses is $115.81 million

    Cost of goods sold

    -
    CGON annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $33.70M
    CGON annual SGA is $33.70 million

    Depreciation and amortization

    $32.00K
    CGON annual depreciation & amortization is $32.00 thousand

    Interest expense

    -
    CGON annual interest expense value is unknown

    Income tax

    -
    CGON annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$114.67M
    CGON annual earnings before interest & taxes is -$114.67 million

    EBITDA

    -$114.63M
    CGON annual EBITDA is -$114.63 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $754.80M
    CGON annual total assets is $754.80 million

    Non current assets

    $587.00K
    CGON annual long term assets is $587.00 thousand

    Current assets

    $754.21M
    CGON annual total current assets is $754.21 million

    Cash and cash equivalents

    $257.07M
    CGON annual cash & cash equivalents is $257.07 million

    Accounts receivable

    -
    CGON annual accounts receivable value is unknown

    Inventory

    -
    CGON annual inventory value is unknown

    Liabilities

    Total liabilities

    $21.42M
    CGON annual total liabilities is $21.42 million

    Long term liabilities

    $52.00K
    CGON annual total long term liabilities is $52.00 thousand

    Current liabilities

    $21.37M
    CGON annual total current liabilities is $21.37 million

    Accounts payable

    $6.52M
    CGON annual accounts payable is $6.52 million

    Debt

    Total debt

    $238.00K
    CGON annual total debt is $238.00 thousand

    Total debt 1-year change

    -48.37%
    CGON annual total debt is down -48.37% year-on-year

    Long term debt

    $52.00K
    CGON annual long term debt is $52.00 thousand

    Short term debt

    $186.00K
    CGON annual short term debt is $186.00 thousand

    Equity & Capital

    Shareholders equity

    $733.38M
    CGON annual stockholders equity is $733.38 million

    Book value

    $733.38M
    CGON annual book value is $733.38 million

    Retained earnings

    -$217.98M
    CGON annual retained earnings is -$217.98 million

    Working capital

    $732.84M
    CGON annual working capital is $732.84 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$78.71M
    CGON annual cash flow from operations is -$78.71 million

    Cash from operations 1-year change

    -72.32%
    CGON annual cash flow from operations is down -72.32% year-on-year

    Cash from investing

    -$300.76M
    CGON annual cash flow from investing activities is -$300.76 million

    Cash from investing 1-year change

    -148.17%
    CGON annual cash flow from investing activities is down -148.17% year-on-year

    Cash from financing

    $628.28M
    CGON annual cash flow from financing activities is $628.28 million

    Cash from financing 1-year change

    +622.18%
    CGON annual cash flow from financing activities is up +622.18% year-on-year

    CAPEX

    CAPEX

    $234.00K
    CGON annual capital expenditures is $234.00 thousand

    CAPEX 1-year change

    -
    CGON annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$78.95M
    CGON annual free cash flow is -$78.95 million

    Free cash flow 1-year change

    -72.83%
    CGON annual free cash flow is down -72.83% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    CGON annual gross profit margin value is unknown

    Operating margin

    -10.07K%
    CGON annual operating profit margin is -10.07 thousand%

    Net margin

    -7729.50%
    CGON annual net profit margin is -7729.50%

    ROA & ROE

    ROA

    -18.45%
    CGON annual return on assets is -18.45%

    ROE

    -19.18%
    CGON annual return on equity is -19.18%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CGON price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CGON price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.89
    CGON price to book ratio is 2.89

    PB ratio Sector rank

    66.09%
    CGON price to book ratio is higher than 66.09% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3076.65
    CGON price to sales ratio is 3076.65

    PS ratio Sector rank

    99.46%
    CGON price to sales ratio is higher than 99.46% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $2.00B
    CGON enterprise value is $2.00 billion

    Enterprise value Sector rank

    81.33%
    CGON enterprise value is higher than 81.33% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -14.86
    CGON EV/EBITDA is -14.86

    EV/EBITDA Sector rank

    10.11%
    CGON EV/EBITDA is higher than 10.11% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    35.30
    CGON annual current ratio is 35.30

    Quick ratio

    -
    CGON annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    CGON annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    CGON annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CGON piotroski f-score value is unknown

    Altman Z-Score

    57.31
    CGON altman z-score is 57.31

    Analyst ratings

    Recent major analysts updates

    Jun 17, 25 Morgan Stanley
    Overweight
    May 19, 25 Morgan Stanley
    Overweight
    May 2, 25 JP Morgan
    Overweight
    Apr 29, 25 RBC Capital
    Outperform
    Apr 28, 25 HC Wainwright & Co.
    Buy
    Apr 28, 25 Cantor Fitzgerald
    Overweight
    Apr 16, 25 Scotiabank
    Sector Perform
    Mar 31, 25 HC Wainwright & Co.
    Buy
    Mar 25, 25 HC Wainwright & Co.
    Buy
    Jan 13, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with CGON included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for CG Oncology, Inc.?
    • Does CG Oncology, Inc. pay dividends?
    • What sector is CG Oncology, Inc. in?
    • What industry is CG Oncology, Inc. in?
    • What country is CG Oncology, Inc. based in?
    • Is CG Oncology, Inc. in the S&P 500?
    • Is CG Oncology, Inc. in the NASDAQ 100?
    • Is CG Oncology, Inc. in the Dow Jones?
    • When was CG Oncology, Inc.'s last earnings report?
    • When does CG Oncology, Inc. report earnings?

    What is the ticker symbol for CG Oncology, Inc.?

    The ticker symbol for CG Oncology, Inc. is NASDAQ:CGON

    Does CG Oncology, Inc. pay dividends?

    No, CG Oncology, Inc. does not pay dividends

    What sector is CG Oncology, Inc. in?

    CG Oncology, Inc. is in the Healthcare sector

    What industry is CG Oncology, Inc. in?

    CG Oncology, Inc. is in the Biotechnology industry

    What country is CG Oncology, Inc. based in?

    CG Oncology, Inc. is headquartered in United States

    Is CG Oncology, Inc. in the S&P 500?

    No, CG Oncology, Inc. is not included in the S&P 500 index

    Is CG Oncology, Inc. in the NASDAQ 100?

    No, CG Oncology, Inc. is not included in the NASDAQ 100 index

    Is CG Oncology, Inc. in the Dow Jones?

    No, CG Oncology, Inc. is not included in the Dow Jones index

    When was CG Oncology, Inc.'s last earnings report?

    CG Oncology, Inc.'s most recent earnings report was on May 13, 2025

    When does CG Oncology, Inc. report earnings?

    The next expected earnings date for CG Oncology, Inc. is August 8, 2025
    On this page